Navigation Links
Widening Application Range to Boost MRI Markets in Eastern Europe, Says Frost & Sullivan
Date:10/13/2009

LONDON, Oct. 13 /PRNewswire/ -- Eastern Europe is poised to be the market to tap into in the near future for magnetic resonance imaging (MRI) manufacturers. These countries have budgets allocated to improve their healthcare systems after becoming members of the European Union (EU). Their installed base of MRI systems is not large, which directly makes this region conducive for market growth. At the same time, market prospects will receive a boost from an expanding application range.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicalimaging.frost.com), Western and Eastern European Markets for MRI, finds that the market earned revenues of $858.2 million in 2008 and estimates this to reach $996.3 million in 2012. The market sectors covered in this research include cardiovascular MRI, breast MRI, functional MRI, interventional MRI, contrast-enhanced MRI, spinal MRI and musculoskeletal MRI.

"Along with constant upgrades in Tesla strength, the number of applications of MRI is increasing from a research point of view," notes Frost & Sullivan Research Analyst Gideon Praveen Kumar. "Moreover, such applications are becoming commercially viable as well."

For most applications, a 1.5 Tesla system, coupled with the use of CAD, will suffice. 3-Tesla systems provide a higher resolution of images, which can prove to be important, especially for more sophisticated clinical applications. MRI scanning has also been used for ophthalmic and other sensory applications, making this a preferred route for dedicated MRI vendors.

However, reimbursement remains an industry-wide constraint for the medical imaging industry. Reimbursement for MRI sc
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
3. Indevus Announces Submission of New Drug Application
4. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
7. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
8. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
9. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
10. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
11. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
(Date:1/14/2014)... PLYMOUTH, Minn. , Jan. 14, 2014   NuAire , a ... come to agreement with Hitachi Koki of ... centrifuges in North America . NuAire will utilize ... and Canada to offer assistance ...
(Date:1/14/2014)... 14, 2014 Equashield ( http://www.equashield.com ... drugs, today announced that it has achieved 60% ...   Equashield,s closed systems reduce the ... and other medical professionals who prepare and administer ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Equashield's Sales Grow by 60% in 2013 2
... Dec. 20 The largest study to examine,the ... depression,significantly worsens a patient,s adherence to highly active ... medication,can reverse this outcome, according to a study ... Group Health Cooperative published in the,current online issue ...
... NEW YORK, Dec. 20 Intra-Cellular Therapies, Inc. ... insomnia (SMI) Phase 2,clinical study using its drug ... receptor antagonist and represents an important new,approach to ... separation of 5-HT2A,and dopamine receptor modulatory activities, ITI ...
Cached Medicine Technology:Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 2Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4
(Date:4/17/2014)... Scientists have identified new pain relief targets that ... pain. BBSRC-funded researchers at King,s College London made ... nerves in the periphery of the body. , ... and identifying mechanisms underlying pain generation and our ... related side effects." , One potential side effect ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:Study sheds light on how the immune system protects children from malaria 2Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2
... Lab in Summit County ... Outside of ... a,cardiology testing and treatment facility located in Hudson, was recently,granted accreditation ... Accreditation of Echocardiography,Laboratories (ICAEL)., "We,re thrilled to have this accreditation, ...
... El-Deiry, MD, PhD, Professor of Medicine, Genetics, and Pharmacology ... been pursuing a cancer-targeting molecule called TRAIL and its ... and curtails tumor spread by binding to a specialized ... cancer patients who often have suppressed immunity, and for ...
... Plus PEG-INTRON Improve Efficacy and Lower Relapse Rates, ... the Disease , Higher Dose, Weight-Based Therapy Justified ... 27, 2007) -- As reported recently in the ... 5,000 patients with hepatitis C virus (HCV) showed ...
... VALLEJO, Calif., Dec. 27 Sutter Solano Medical Center,(SSMC) ... Winner. The hospital,was recognized in the Emergency Department (ED) ... scores compared to all,other facilities being measured., The ... achievement in the,health care industry that is bestowed annually, ...
... ALTO, Calif., Dec. 27 Garry W. Rogerson,President and ... the 26th,annual JPMorgan Healthcare Conference in San Francisco on ... A live webcast of the presentation will be publicly ... Go to, http://www.varianinc.com and click on "Investors." An ...
... National Institute of Environmental Health Sciences (NIEHS), part ... a total of $6.8 million for the first ... called DISCOVER - Disease Investigation Through Specialized Clinically-Oriented ... are expected to bridge the gap between basic ...
Cached Medicine News:Health News:Western Reserve Heart Care Receives ICAEL Echocardiography Accreditation 2Health News:Cell-death receptor links cancer susceptibility and inflammation 2Health News:In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment 2Health News:In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment 3Health News:In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment 4Health News:Sutter Solano Medical Center Wins National Improvement Award 2Health News:NIEHS awards DISCOVER grants 2Health News:NIEHS awards DISCOVER grants 3
... The NormoFlow™ System is the only ... during high volume surgical irrigation, especially ... room warm, regardless of length of ... provides safe, consistent performance and is ...
... The Hemokinetitherm is a ruggedly built, simple ... stable temperature for the controlled warming of blood ... This temperature is maintained by a water reservoir ... by a proportional controller which is backed up ...
Are you looking for an inexpensive, effective Blood and Infusion Warmer? , ,Animec is an economical fluid warmer that uses standard I.V. tubing instead of special disposable sets....
... complete anesthesia solution for the MRI environment , ... , ,The Narkomed MRI-2 is the ... VPO monitor, designed and engineered to perform, without ... MRI environments of up to 3.0 Tesla. This ...
Medicine Products: